首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Expert Opinion On Drug Metabolism & Toxicology

Expert Opinion On Drug Metabolism & Toxicology杂志,由Taylor and Francis Ltd.出版,于2005年创刊,Bimonthly,出版语言English,ISSN:1742-5255,E-ISSN:1744-7607。

投稿咨询
Expert Opinion On Drug Metabolism & Toxicology
Expert Opinion On Drug Metabolism & Toxicology
Expert Opinion On Drug Metabolism & Toxicology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
3区
影响因子
4.5
CiteScore
5.6
期刊收录
SCI、SCIE

Expert Opinion On Drug Metabolism & Toxicology(中文译名:《药物代谢与毒理学专家意见》),ISSN:1742-5255,EISSN:1744-7607,是Taylor and Francis Ltd.出版的国际性学术期刊,创刊于2005年,以Bimonthly形式稳定发行,2026年总发文量约78篇。该刊采用非OA开放访问,学科归属为医学 - 生化与分子生物学。该刊是医学、生化与分子生物学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.5,2025年期刊CiteScore为5.6,2025年期刊自引率约2.2%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Expert Opinion On Drug Metabolism & Toxicology长期聚焦医学、生化与分子生物学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、生化与分子生物学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAItaly、CHINA MAINLAND、England、Netherlands、GERMANY (FED REP GER)、Australia等为核心发文国家与地区;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)SAPIENZA UNIVERSITY ROME、KU LEUVEN、ERASMUS UNIVERSITY ROTTERDAM、UNIVERSITA DELLA CAMPANIA VANVITELLI、UNIVERSITY OF MESSINA、UNIVERSITY OF PISA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
3区 3区 3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
TOXICOLOGY 毒理学 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学
2区 3区 3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
2区 2区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q2 103 / 328

68.8

学科:PHARMACOLOGY & PHARMACY SCIE Q2 90 / 356

74.9

学科:TOXICOLOGY SCIE Q1 26 / 106

75.9

学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q3 215 / 328

34.6

学科:PHARMACOLOGY & PHARMACY SCIE Q3 218 / 356

38.9

学科:TOXICOLOGY SCIE Q3 78 / 106

26.89

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q2 138 / 320

57

学科:PHARMACOLOGY & PHARMACY SCIE Q2 113 / 352

68

学科:TOXICOLOGY SCIE Q2 34 / 106

68.4

学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q3 222 / 321

31

学科:PHARMACOLOGY & PHARMACY SCIE Q3 221 / 353

37.54

学科:TOXICOLOGY SCIE Q3 78 / 106

26.89


中国学者近期发文

1
Post-marketing pharmacovigilance of tedizolid: emerging safety signal

Author:Yao, Haiping; Gan, Guoping; Wang, Zhu

Journal: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2026; Vol. 22, Issue 4, pp. 289-298. DOI: 10.1080/17425255.2026.2660710

2
Substrate-specificity of pharmacogenomic variability - clinical relevance and emerging predictive strategie

Author:Zhou, Yitian; Park, Yoomi; Lauschke, Volker M

Journal: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2026; Vol. 22, Issue 3, pp. 201-215. DOI: 10.1080/17425255.2026.2654466

3
Microbiome-driven PKs: redefining drug metabolism beyond host enzyme

Author:Belancic, Andrej; Fajkic, Almir; Wah Lam, Yun; Alic, Lejla; Labriffe, Marc; Pilipovic, Kristina; Dzidic-Krivic, Amina; Yee Sy, Hing; Jankovic, Slobodan

Journal: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17425255.2026.2631415

4
A comparative study on the consistency of different decision support software systems from the perspective of potential drug-drug interactions in intensive care unit patient

Author:Han, Furong; Cheng, Xiao; Li, Yiman; Bai, Jie; Dong, Liming; Wang, Jiawei

Journal: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/17425255.2025.2511961

5
Bioequivalence of generic and branded ibrutinib capsules in healthy Chinese volunteers under fasting and fed conditions: a randomized, four-period, fully replicated, crossover stud

Author:Zhang, Rong; Chong, Rui; Yang, Shaomei; He, Kun; Wen, Qing

Journal: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/17425255.2025.2496459

6
Mass balance and metabolite profiles in humans of tegoprazan, a novel potassium-competitive acid blocker, using 14C-radiolabelled technique

Author:Bian, Yicong; Yuan, Jinjie; Ma, Sheng; Nan, Jiang; Gu, Zheming; Feng, Hao; Yu, Zhenwen; Liu, Zhenteng; Xie, Fang; Wang, Yinghui; Liu, Chengxin; Zhang, Hua; Miao, Liyan

Journal: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/17425255.2025.2505637

7
Regulation of cyclophosphamide induced hepatotoxicity by REV-ERBα modifier

Author:Wang, Jinyi; Cui, Jialu; Hao, Tingying; Zhang, Qi; Chen, Yutong; Guo, Lianxia; Tong, Yongbin; Dong, Dong

Journal: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/17425255.2025.2490741

8
A comprehensive review of the efficacy and safety of ertugliflozi

Author:Xu, Bo; Liu, Yilin; Zhang, Tianqiao; He, Zunbo; Zhou, Jiecan

Journal: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/17425255.2025.2457393


在线咨询

Expert Opinion On Drug Metabolism & Toxicology

国际简称:EXPERT OPIN DRUG MET参考译名:药物代谢与毒理学专家意见

年发文量:78 CiteScore:5.6 是否预警:否 Gold OA文章占比:4.69% 研究类文章占比:2.56%

杂志社联系方式:INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

Expert Opinion On Drug Metabolism & Toxicology